Cargando…

Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts

BACKGROUND: Diabetes mellitus (DM), either preexisting or developing after transplantation, remains a crucial clinical problem in kidney transplantation. To obtain insights into the molecular mechanisms underlying PTDM development and early glomerular damage before the development of histologically...

Descripción completa

Detalles Bibliográficos
Autores principales: Kipp, Anne, Marti, Hans-Peter, Babickova, Janka, Nakken, Sigrid, Leh, Sabine, Halden, Thea A. S., Jenssen, Trond, Vikse, Bjørn Egil, Åsberg, Anders, Spagnoli, Giulio, Furriol, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464146/
https://www.ncbi.nlm.nih.gov/pubmed/37626301
http://dx.doi.org/10.1186/s12882-023-03294-z
_version_ 1785098401006747648
author Kipp, Anne
Marti, Hans-Peter
Babickova, Janka
Nakken, Sigrid
Leh, Sabine
Halden, Thea A. S.
Jenssen, Trond
Vikse, Bjørn Egil
Åsberg, Anders
Spagnoli, Giulio
Furriol, Jessica
author_facet Kipp, Anne
Marti, Hans-Peter
Babickova, Janka
Nakken, Sigrid
Leh, Sabine
Halden, Thea A. S.
Jenssen, Trond
Vikse, Bjørn Egil
Åsberg, Anders
Spagnoli, Giulio
Furriol, Jessica
author_sort Kipp, Anne
collection PubMed
description BACKGROUND: Diabetes mellitus (DM), either preexisting or developing after transplantation, remains a crucial clinical problem in kidney transplantation. To obtain insights into the molecular mechanisms underlying PTDM development and early glomerular damage before the development of histologically visible diabetic kidney disease, we comparatively analysed the proteome of histologically normal glomeruli from patients with PTDM and normoglycaemic (NG) transplant recipients. Moreover, to assess specificities inherent in PTDM, we also comparatively evaluated glomerular proteomes from transplant recipients with preexisting type 2 DM (T2DM). METHODS: Protocol biopsies were obtained from adult NG, PTDM and T2DM patients one year after kidney transplantation. Biopsies were formalin-fixed and embedded in paraffin, and glomerular cross-sections were microdissected. A total of 4 NG, 7 PTDM and 6 T2DM kidney biopsies were used for the analysis. The proteome was determined by liquid chromatography-tandem mass spectrometry. Relative differences in protein abundance and significantly dysregulated pathways were analysed. RESULTS: Proteins involved in cell adhesion, immune response, leukocyte transendothelial filtration, and cell localization and organization were less abundant in glomeruli from PTDM patients than in those from NG patients, and proteins associated with supramolecular fibre organization and protein-containing complex binding were more abundant in PTDM patients. Overall, proteins related to adherens and tight junctions and those related to the immune system, including leukocyte transendothelial migration, were more abundant in NG patients than in transplanted patients with DM, irrespective of the timing of its development. However, proteins included in cell‒cell junctions and adhesion, insulin resistance, and vesicle-mediated transport were all less abundant in PTDM patients than in T2DM patients. CONCLUSIONS: The glomerular proteome profile differentiates PTDM from NG and T2DM, suggesting specific pathogenetic mechanisms. Further studies are warranted to validate these results, potentially leading to an improved understanding of PTDM kidney transplant pathophysiology and to the identification of novel biomarkers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03294-z.
format Online
Article
Text
id pubmed-10464146
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104641462023-08-30 Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts Kipp, Anne Marti, Hans-Peter Babickova, Janka Nakken, Sigrid Leh, Sabine Halden, Thea A. S. Jenssen, Trond Vikse, Bjørn Egil Åsberg, Anders Spagnoli, Giulio Furriol, Jessica BMC Nephrol Research Article BACKGROUND: Diabetes mellitus (DM), either preexisting or developing after transplantation, remains a crucial clinical problem in kidney transplantation. To obtain insights into the molecular mechanisms underlying PTDM development and early glomerular damage before the development of histologically visible diabetic kidney disease, we comparatively analysed the proteome of histologically normal glomeruli from patients with PTDM and normoglycaemic (NG) transplant recipients. Moreover, to assess specificities inherent in PTDM, we also comparatively evaluated glomerular proteomes from transplant recipients with preexisting type 2 DM (T2DM). METHODS: Protocol biopsies were obtained from adult NG, PTDM and T2DM patients one year after kidney transplantation. Biopsies were formalin-fixed and embedded in paraffin, and glomerular cross-sections were microdissected. A total of 4 NG, 7 PTDM and 6 T2DM kidney biopsies were used for the analysis. The proteome was determined by liquid chromatography-tandem mass spectrometry. Relative differences in protein abundance and significantly dysregulated pathways were analysed. RESULTS: Proteins involved in cell adhesion, immune response, leukocyte transendothelial filtration, and cell localization and organization were less abundant in glomeruli from PTDM patients than in those from NG patients, and proteins associated with supramolecular fibre organization and protein-containing complex binding were more abundant in PTDM patients. Overall, proteins related to adherens and tight junctions and those related to the immune system, including leukocyte transendothelial migration, were more abundant in NG patients than in transplanted patients with DM, irrespective of the timing of its development. However, proteins included in cell‒cell junctions and adhesion, insulin resistance, and vesicle-mediated transport were all less abundant in PTDM patients than in T2DM patients. CONCLUSIONS: The glomerular proteome profile differentiates PTDM from NG and T2DM, suggesting specific pathogenetic mechanisms. Further studies are warranted to validate these results, potentially leading to an improved understanding of PTDM kidney transplant pathophysiology and to the identification of novel biomarkers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03294-z. BioMed Central 2023-08-25 /pmc/articles/PMC10464146/ /pubmed/37626301 http://dx.doi.org/10.1186/s12882-023-03294-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Kipp, Anne
Marti, Hans-Peter
Babickova, Janka
Nakken, Sigrid
Leh, Sabine
Halden, Thea A. S.
Jenssen, Trond
Vikse, Bjørn Egil
Åsberg, Anders
Spagnoli, Giulio
Furriol, Jessica
Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts
title Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts
title_full Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts
title_fullStr Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts
title_full_unstemmed Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts
title_short Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts
title_sort glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464146/
https://www.ncbi.nlm.nih.gov/pubmed/37626301
http://dx.doi.org/10.1186/s12882-023-03294-z
work_keys_str_mv AT kippanne glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts
AT martihanspeter glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts
AT babickovajanka glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts
AT nakkensigrid glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts
AT lehsabine glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts
AT haldentheaas glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts
AT jenssentrond glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts
AT viksebjørnegil glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts
AT asberganders glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts
AT spagnoligiulio glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts
AT furrioljessica glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts